Skip to content

Pharminent

cropped-ChatGPT-Image-Jun-22-2026-05_46_48-PM.png
Primary Menu
  • Home
  • Signal News
  • Biopharma Brief
    • Market Access Intelligence
    • Rare Disease Gene Therapy
    • Oncology
  • Week in Review
    • GLP-1 Competitive Market
    • NeuroMarket Pulse
      • Neurology Interactive Calendar
    • Manufacturing Intelligence
  • Contact
Light/Dark Button
Brief
  • Home
  • Commercial
  • Wegovy pill launches in UK as first daily oral GLP1 for weight management
  • Commercial

Wegovy pill launches in UK as first daily oral GLP1 for weight management

PharmaTimes

Option offers oncedaily semaglutide tablets for adults living with obesity

Metabolic & GLP-1

Read full story

pharminent July 6, 2026 (Last updated: July 8, 2026)

PharmaTimes

Option offers oncedaily semaglutide tablets for adults living with obesity

Metabolic & GLP-1

Read full story

Sign up to receive free daily digest

Check your inbox or spam folder to confirm your subscription.

Post navigation

Previous: UK, pharma industry pilot rapid access routes for medicines
Next: Roche looks to Astex in $515m breast cancer deal

Related Stories

  • Commercial

Tryngolza charts blockbuster course after FDA’s hypertriglyceridemia approval

pharminent June 26, 2026
  • Commercial

Lilly launches its LillyDirect sales channel in the UK

pharminent June 25, 2026
  • Commercial

Post-marketing oncology studies: Enabling faster recruitment and lower costs

pharminent June 22, 2026

You May Have Missed

  • News

Novartis Pays $1.1B Upfront for Myricx Bio ADC Platform

pharminent July 7, 2026
sample_feature_2026-06-23
  • News

Vera’s TRUTAKNA Wins FDA Accelerated Approval for IgA Nephropathy

pharminent July 7, 2026
  • M&A / Deals

Vertex buys Crinetics for $10bn in endocrinology drive

pharminent July 7, 2026
  • Regulatory

EC approves AbbVie’s Tepkinly combination for follicular lymphoma

pharminent July 7, 2026
© 2026 All rights reserved. | ReviewNews by AF themes.